DYRK1A and Dravet syndrome: EGCG inhibition of the overexpressed dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A (Dyrk1A) protein has shown benefits in neuronal plasticity processes in DS patients [85], which may be another potential molecular pathway to study in FASD and a therapeutic target for cognitive disorders.